Get to the crux of the matter faster with our unique blend of data, analytics, and expertise. Whether you need a broad market overview or a detailed product or company analysis, Evaluate takes you from exploration to full understanding quickly and accurately.
Your go-to source for consensus forecasts that distil a wealth of equity analyst research into a single viewpoint.
Harness game-changing insight into pharma asset potential, made possible by machine learning and millions of data points across the full clinical lifecycle.
Build a clear commercial understanding of disease burden, patient populations, and the value of an indication.
Get expert, evidence-led answers to your unique Portfolio Strategy, Licensing, Transaction Advisory, and Competitive Intelligence questions.
Leveraging a foundation of extensive Evaluate data, augmented with secondary research, modelling and analysis, our pharmaceutical consulting solutions are data-driven and insight-focused. We also conduct targeted primary research with Key Opinion Leaders, Healthcare Professionals and Payers to validate our assumptions and test our hypotheses.
As part of Norstella, our team has access to an unparalleled range of insights, expertise and deep industry knowledge.
Understand the pharmaceutical market’s past, present, and future performance with over two decades of commercial data and a continually extending window of consensus forecasts. Access a richer view that uniquely links consensus forecasts to pipelines across indications, therapeutic areas, and mechanisms of action.
Put the power of machine learning to work. Analyse millions of data points across the full clinical pipeline to discern critical connections between risk and return. Highlight promising drugs and forecast R&D expenses, drug prices, and market entry timelines like never before.
Identify commercial opportunities, confidently target clinical needs, and accurately gauge an asset’s worth. Interrogate comprehensive patient segmentation data down to the level of detail you need.
Easily monitor, compare, and predict trends in the global medical device and diagnostic market. Assess the competition, recognise risks and opportunities for action, and pinpoint immediate priorities.
Understand the European pharma landscape in detail. Scan the R&D horizon and size market opportunity supported by product consensus forecasts.
Refine your product and portfolio valuations for the Japanese market using country-specific consensus forecasts. Anticipate future trends, compare with global markets, benchmark product outcomes, and more.
Analyse the dealmaking landscape in detail. View key deal provisions, find deal comparables, and explore best practices in contract drafting and alliance negotiation.
Accelerate your growth in the evolving CDMO landscape. Use our tailored tool for robust CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and more.
From diagnoses to drugs, procedures to test results, and the care provided by their HCPs, real-world data provides insights that can drive patient-focused strategies.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Find and validate pharma opportunities with a robust assessment of market fit, risk, uptake and sales forecasts, and more.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Build a better understanding of your growth drivers and product differentiators with a clear analysis of market dynamics, trends, unmet needs, and competitors.
Determine the true worth and potential of assets, score high-value opportunities, and make confident licensing or acquisition decisions.
Triangulate internal assumptions and power your allocation strategy with external benchmarking data across the R&D landscape.
Save time and effort with our custom data feeds when you want to augment or drill down on specific pharma and biotech datasets. Get the exact data and analyses you need, integrated smoothly into your data warehouse and workflows.